Arcus Biosciences Inc
NYSE:RCUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arcus Biosciences Inc
NYSE:RCUS
|
US |
|
Puma SE
OTC:PMMAF
|
DE |
|
A
|
AG Mortgage Investment Trust Inc
F:8AGA
|
US |
|
Volatus Aerospace Inc
TSX:FLT
|
CA |
|
C
|
Carter's Inc
F:HCH
|
US |
|
OPTIMIZERx Corp
NASDAQ:OPRX
|
US |
|
Toast Inc
NYSE:TOST
|
US |
|
C
|
Censof Holdings Bhd
KLSE:CENSOF
|
MY |
|
S
|
Swire Properties Ltd
HKEX:1972
|
HK |
Wall St Price Targets
RCUS Price Targets Summary
Arcus Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
RCUS is 36.55 USD with a low forecast of 22.22 USD and a high forecast of 49.35 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RCUS's stock price target?
Price Target
36.55
USD
According to Wall Street analysts, the average 1-year price target for
RCUS is 36.55 USD with a low forecast of 22.22 USD and a high forecast of 49.35 USD.
What is the Revenue forecast for Arcus Biosciences Inc?
Projected CAGR
35%
Over the last 8 years, the compound annual growth rate for Revenue has been 91%. The projected CAGR for the next 8 years is 35%.